Barostim will be featured across eight events at HFSA, including late-breaking clinical data, a rapid-fire session, posters and podium sessions. BENEFIT-HF, the landmark clinical trial initiated ...

The AMA CPT editorial panel accepted a Category I CPT codes application for the Barostim therapy due to its rising use and strong clinical evidence. Credit: MacroEcon / Shutterstock. · Medical Device ...

CVRx's Barostim is a long-term compounder that presents with interesting economics. Clinical data is robust for the device and it continues to benefit from regulatory tailwinds. News around the device ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CVRx CVRX announced that Devoted Health has issued a Medicare Advantage coverage policy for its Barostim therapy, effective July 17, 2026. The policy covers patients under the current FDA-approved ...

CVRx Inc. CVRX announced a key reimbursement win after Humana issued a Medicare Advantage coverage policy for its Barostim therapy. The development marks an important step in expanding patient access ...

CVRx, a medical device company developing neuromodulation therapies for cardiovascular diseases, has appointed John Landry as ...

The BAROSTIM THERAPY™ in Resistant Hypertension registry, officially titled “BAROSTIM THERAPY™ In Resistant Hypertension: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System,” tracks ...

CVRx shares were 19% higher, at $8.48, after the company said that the Centers for Medicare and Medicaid Services has proposed keeping CVRx's Barostim implant procedure as part of the New Technology ...

The study called “BAROSTIM THERAPY in Heart Failure With Reduced Ejection Fraction” is a post-market registry run by CVRx, Inc. It tracks real-world outcomes for patients getting Barostim therapy for ...

CVRx, Inc. announced at the Technology and Heart Failure Therapeutics (THT) conference that new real-world evidence demonstrates significant reductions in hospital visits and length of stay after ...

When medication stops working for people with congestive heart failure there are few options. A few months ago, Joe Knox couldn't take a simple walk due to his congestive heart failure. "I couldn't ...